{"id":721,"date":"2020-09-03T13:55:17","date_gmt":"2020-09-03T20:55:17","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=721"},"modified":"2020-09-08T13:56:15","modified_gmt":"2020-09-08T20:56:15","slug":"disease-severity-dictates-sars-cov-2-specific-neutralizing-antibody-responses-in-covid-19","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/09\/03\/disease-severity-dictates-sars-cov-2-specific-neutralizing-antibody-responses-in-covid-19\/","title":{"rendered":"Disease Severity Dictates SARS-CoV-2-Specific Neutralizing Antibody Responses in COVID-19"},"content":{"rendered":"<ul>\n<li>Greater disease severity was associated with higher levels of serum neutralizing capacity among 59 patients recovered from COVID-19 in China. Generation of antibodies capable of completely neutralizing pseudovirus was observed in 80% of patients who recovered from severe illness, while asymptomatic patients failed to generate competent neutralizing antibodies. Complete neutralization was observed in 47% of recovered patients with moderate symptoms and 25% of those with mild symptoms.<\/li>\n<\/ul>\n<p><em>Chen et al. (Sept 2, 2020). Disease Severity Dictates SARS-CoV-2-Specific Neutralizing Antibody Responses in COVID-19. Signal Transduction and Targeted Therapy. <a href=\"https:\/\/doi.org\/10.1038\/s41392-020-00301-9\">https:\/\/doi.org\/10.1038\/s41392-020-00301-9<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Greater disease severity was associated with higher levels of serum neutralizing capacity among 59 patients recovered from COVID-19 in China. Generation of antibodies capable of completely neutralizing pseudovirus was observed in 80% of patients who recovered from severe illness, while asymptomatic patients failed to generate competent neutralizing antibodies. Complete neutralization was observed in 47% of&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/09\/03\/disease-severity-dictates-sars-cov-2-specific-neutralizing-antibody-responses-in-covid-19\/\">Read more<\/a><\/div>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[32],"topic":[31],"class_list":["post-721","post","type-post","status-publish","format-standard","hentry","category-article-summary","tag-immunity","topic-vaccines-and-immunity"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/721","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=721"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/721\/revisions"}],"predecessor-version":[{"id":722,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/721\/revisions\/722"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=721"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=721"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=721"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=721"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}